Verified by Herlev Hospital, August 2010...
Nyt studie med belinostat i kombination med erlotinib hos patienter med ikke-småcellet lungekræft er undervejs.
Samarbejdspartnere: Københavns Universitetshospital Herlev, Bispebjerg Hospital, TopoTarget og Roche Pharma AG...
http://www.clinicaltrials.gov/ct2/show?term=belinostat&rank=15
Nyt studie med belinostat i kombination med erlotinib hos patienter med ikke-småcellet lungekræft er undervejs.
Samarbejdspartnere: Københavns Universitetshospital Herlev, Bispebjerg Hospital, TopoTarget og Roche Pharma AG...
http://www.clinicaltrials.gov/ct2/show?term=belinostat&rank=15
De "stora läkemedelsbolagen" ökade intresse för "drug cocktails"
Cocktails Are Next For Cancer-Drug Makers
"different approaches to combination treatments. Pfizer (PFE), the world's biggest drugmaker, and Roche, the world's largest maker of cancer medicines, are developing the needed parts in their labs. Roche's leading combination began safety tests in patients this year, and Pfizer has four combinations in early human trials."
26 aug 2010
http://www.businessweek.com/magazine/content/10_36/b4193020841268.htm
Cocktails Are Next For Cancer-Drug Makers
"different approaches to combination treatments. Pfizer (PFE), the world's biggest drugmaker, and Roche, the world's largest maker of cancer medicines, are developing the needed parts in their labs. Roche's leading combination began safety tests in patients this year, and Pfizer has four combinations in early human trials."
26 aug 2010
http://www.businessweek.com/magazine/content/10_36/b4193020841268.htm
